Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Atropselective synthesis of N-aryl pyridones via dynamic kinetic resolution enabled by non-covalent interactions

Jamie S. Sweet , Ruichen Wang , Panagiotis Manesiotis , Paul Dingwall and Peter C. Knipe *
School of Chemistry and Chemical Engineering, Queen's University Belfast, David Keir Building, Belfast, BT9 5AG, UK. E-mail: p.knipe@qub.ac.uk; Web: http://www.knipechem.co.uk

Received 27th January 2022 , Accepted 8th February 2022

First published on 8th March 2022


Abstract

The dynamic kinetic resolution of C–N atropisomeric pyridones was achieved via asymmetric phase-transfer catalysis, exploiting a rotational barrier-lowering hydrogen bond in the starting materials. X-ray and NMR experiments revealed the presence of a barrier-raising ground state CH⋯π interaction in the product, supported by DFT calculations. A co-crystal of the quinidine-derived phase-transfer catalyst and substrate reveals key substrate–catalyst non-covalent interactions.


Chiral atropisomeric C–N axes have gained increasing interest, not least due to bioactive compounds such as sotorasib, a first-in-class KRAS inhibitor for the treatment of non-small-cell lung cancer (Fig. 1A). Axially chiral acetanilides also comprise a class of potent herbicides including metolachlor and dimethenamid. The asymmetric synthesis of such molecules has therefore been the subject of synthetic efforts.1 Recent catalytic strategies include proximal C–N bond formation (where the C–N bond formed is not the axial bond),2ortho-CH functionalisation,3 desymmetrisation by remote functionalization,4de novo pyridone synthesis by cycloaddition,5 and direct, intermolecular axial amination (Fig. 1B).6 During a research programme directed at synthesizing N-arylpyridinium and quinolinium salts7 we became interested in the atropselective synthesis of 2-pyridones. We were intrigued by reports by Smith, Paton et al.8 that phase-transfer catalysed (PTC) dynamic kinetic resolution (DKR) formed axially chiral benzamides, enabled by a transition state-lowering hydrogen bond in the phenol substrates (Fig. 1C).9 This approach has never been applied to axially chiral 2-pyridones.10A priori it was unclear if the rotational barrier in an N-aryl pyridone starting material would be sufficiently low to allow a DKR to be achieved, rather than a kinetic resolution. However, we reasoned that the ability of the starting material to form a 7-membered OH⋯O hydrogen bond may reduce its rotational barrier compared with an alkylated product enabling DKR (Fig. 1D).
image file: d2ob00177b-f1.tif
Fig. 1 Background to this study.

The rotational barriers of these compounds (generated from anisidine derivatives 1a–c and 1,3-diarylpropynones 2a–2c according to the method of Tang, Pan et al.11) were measured experimentally (Scheme 1). Values for 3a–3c were similar in magnitude, while 3-ethyl 3d had a slightly higher barrier and 3-acetylated pyridone 3e had this a significantly higher value. These barriers and the corresponding racemisation half-lives demonstrated that a DKR may be possible in a reaction lasting several hours. Early screening showed cinchonidinium catalyst C1 to generate benzylated product 4a in 66% ee (Table 1). Use of benzyl iodide in place of bromide (entry 2) gave a small increase in ee to −73%. O-Allyl catalyst C2 significantly decreased enantioselectivity (entry 3), suggesting hydrogen bonding to the alcohol is important. Quinine-derived catalyst C3 gave a slight increase in ee relative to C1 that lacks the quinoline methoxy substituent, and its pseudo-enantiomer C4 gave the opposite enantiomeric product in 85% ee (entry 5). The conversion under these conditions was low, so to make the reaction a practical synthetic method the temperature was increased to 35 °C, with the drop in ee to 80% a necessary but acceptable compromise (entry 6).


image file: d2ob00177b-s1.tif
Scheme 1 Synthesis of 2′-hydroxyphenyl-2-pyridone substrates. Rotational barriers (in kJ mol−1) were determined by thermal racemization analysis on enantiopure samples obtained by analytical HPLC on a chiral stationary phase.
Table 1 Selected optimization data for enantioselective dynamic kinetic resolution (see ESI† for full screening)a

image file: d2ob00177b-u1.tif

Entry Catalyst Bn–X (eq.) T (°C) Approx. conv.b (%) eec (%)
a Reactions conducted on 41 μmol scale in CHCl3. b Conversion approximated by visual inspection of TLC plates and divided into the categories: <25%, 25–50%, 50–75%, >75%. c Determined by HPLC on a chiral stationary phase.
1 C1 BnBr (0.6) rt <25 −66
2 C1 BnI (0.6) rt <25 −73
3 C2 BnI (0.6) rt <25 −33
4 C3 BnI (5) rt <25 −76
5 C4 BnI (5) rt <25 85
6 C4 BnI (5) 35 50–75 80


The scope of the asymmetric reaction was then explored (Table 2). Treatment of 3a–e with benzyl iodide gave products 4a,d,g,j,m in generally good yields but with a wide range of ees. Those lacking substitution at the pyridone 3-position generally gave higher ee, (65–77%), while the 3-ethyl product 4j gave a much lower 40% ee, and 3-acetyl compound 4m was obtained with a meagre 6% ee. This pattern, wherein substitution at the pyridone 3-position is poorly tolerated, was further borne out in reaction with electron-deficient and electron-rich benzylating agents. Lastly, alkylation with prenyl bromide gave the product 4p with 47% ee, slightly lower than the benzylated products derived from the same phenol 4g–i. The rotational barriers of the products were measured and displayed only minimal variation across the products formed. The barriers of the products are approximately 25 kJ mol−1 higher than the phenol starting materials, supporting the hypothesis that the absence of the hydrogen bond donor leads to an increased transition state energy in the products. Eyring analysis also allowed the room temperature racemization half-lives of the products to be estimated as >1.6 years (see ESI).

Table 2 Substrate scope and limitations of dynamic kinetic resolutiona

image file: d2ob00177b-u2.tif

Product R1 R2 R3 Yieldb (%) eec (%) ΔG353 Kd (kJ mol−1)
a Typical procedure: 2-pyridone (0.3 mmol), benzyl iodide (5 eq.), catalyst C4 (15 mol%), CHCl3 (11 mL), K2CO3 (50% aq., 205 μL, 5 eq.), 35 °C, 42 h. b Yields are for isolated material. c Enantiomeric excesses determined by HPLC on a chiral stationary phase with reference to a racemic standard. d Rotational barriers determined by HPLC sampling from a DMSO solution held at 353 K. e Not determined since low ee of material made experimental error in measurement unacceptably high.
4a Bn C6H5 H 77 75 121.3
4b p-CNBn C6H5 H 80 67 122.3
4c 4-MeBn C6H5 H 76 70 122.1
4d Bn p-C6H4CH3 H 70 77 121.8
4e 4-CNBn p-C6H4CH3 H 86 67 122.2
4f 4-MeBn p-C6H4CH3 H 66 60 122.7
4g Bn p-C6H4F H 70 65 122.7
4h 4-CNBn p-C6H4F H 86 58 122.3
4i 4-MeBn p-C6H4F H 63 51 122.5
4j Bn C6H5 Et 53 40 121.0
4k 4-CNBn C6H5 Et 70 28 120.6
4l 4-MeBn C6H5 Et 33 41 120.4
4m Bn C6H5 Ac 66 6 122.6
4n 4-CNBn C6H5 Ac 69 3 N.D.e
4o 4-MeBn C6H5 Ac 54 5 121.7
4p Prenyl p-C6H4F H 79 47 121.5


The intolerance of the reaction to substitution at the pyridone 3-position merits discussion. Substitution at this position increases rotational barriers in the starting materials (see Scheme 1). The reasons for this are primarily steric buttressing for the 3-ethyl compounds,12 but may also have an electronic component for 3e, where the acetyl group's electron-withdrawing effect may reduce the basicity of the lactam carbonyl, leading to a weaker (and less stabilising) hydrogen bond in the enantiomerisation transition state. Substitution at the 3-position may therefore impact the enantioselectivity through: (i) steric clashing with catalyst C4 that prevents tight binding when the 3-position is substituted; (ii) the increased barrier to rotation may cause 3d and 3e to operate partially or fully in a KR regime, rather than DKR; and (iii) tight catalyst binding may require rotation around the axis in an induced fit manner, so when the barrier is high, catalyst–substrate binding becomes less energetically favourable.

Single crystal X-ray diffraction of (+)-4b allowed assignment of the major enantiomeric product, and to examine the structure and conformation of the products alongside racemic crystals of 4a, 4j and 4m (Fig. 2A). The absolute stereochemistry of 4b is (Ra), and we assume by extension that the (Ra)-atropisomer is favoured in all products. An unexpected tilt was observed in the crystal structures of all products (θ), with values ranging from 10.3° (4b) to 15.6° (4m). The cause of this tilt is the formation of a CH⋯π interaction between the ortho-CH of the benzyl group and the π-system of the 2-pyridone.13 Aromatic C–H signals for the 4-cyanobenzyl group are shifted upfield by 0.14 (HA) and 0.09 (HB) ppm relative to the control,15 consistent with the upfield shifts observed by Jennings and Malone in related CH⋯π systems.16 This interaction has a stabilising influence on the ground state that is necessarily absent in the enantiomerisation transition state, increasing the overall barrier to racemisation. Rotational profiles of selected starting materials, deprotonated phenolate intermediates and products were examined by DFT (see ESI). These calculations emphasise the importance of hydrogen bonding in this reaction manifold. The rotational barrier in the starting material is lowered through the transition state OH⋯O interaction, whilst the deprotonated intermediate lacking this stabilising interaction displays a significantly higher barrier. The product barrier is raised through the ground state CH⋯π stabilising interaction observed in the crystal structure, supported by 1H chemical shift values, and replicated in solution phase calculations (Fig. 2C).


image file: d2ob00177b-f2.tif
Fig. 2 A. Single crystal X-ray structures of (+)-4b, 4a, 4j and 4m (CCDC 2124210, 2124211, 2124208 and 2124209 respectively). The values of φ and d and their standard uncertainties are obtained directly from the .cif file. The angle between the indicated atoms (*) was measured using Mercury14 and used to determine the value of θ. B. Comparison between selected 1H NMR chemical shifts for 4b and control 5[thin space (1/6-em)]15 indicative of CH⋯π interaction. Δδ calculated as δ(4b) − δ(5). C. Non-Covalent Interaction (NCI) surface of the minimum of 4a showing a stabilising CHA–π interaction in light blue (circled). The colour spectrum ranges from blue (strongly attractive) to green (weakly attractive) to yellow (mildly repulsive) to red (strongly repulsive), geometries optimised at B3LYP-D3/6-31G(d,p).

To understand the origin of asymmetric induction we attempted to co-crystallize the substrate (3c) anion with the catalyst (C4) cation (Fig. 3A). The only crystals obtained were of the desired ion pair, alongside a second neutral substrate molecule presumably formed through protonation by adventitious water during prolonged recrystallization (Fig. 3B). The proton acts as a bridge between the oxygen atoms, and it is likely irrelevant which phenol formally bears the negative charge since the proton is in rapid exchange. The importance of phenol-phenolate heterodimers in (achiral) PTC has previously been noted by Denmark,17 and for certain ammonium salt catalysts it has been suggested that the [PhO–H⋯OPh] heterodimer is directly involved in the SN2 alkylation.18 Here, the proton-bridged phenolate dimer contains both the (Ra)- and (Sa)-configured biaryls, where the former corresponds to the major enantiomer formed in the catalytic reaction. The complexity of this ternary structure precludes definitive statements regarding asymmetric induction. However, ground-state observations may aid the community in understanding how anionic intermediates bind to cinchona-derived ammonium salts.19 The following interactions are evident: (i) the phenoxide is engaged in a O–H⋯O hydrogen bond with the secondary alcohol of the catalyst (Fig. 3C). This interaction has previously been noted,19,21 and is evidently important for asymmetric induction since O-allyl catalyst C2 gave much poorer enantioselectivity (see Table 1); (ii) a short contact between the pyridone C[double bond, length as m-dash]O and the CH3 of the catalyst suggests an n → σ* interaction (Fig. 3D), consistent with the “oxyanion hole” previously described by Wong;22 (iii) a series of two N+Cα-H⋯O and two Cβ–H⋯π interactions acting in unison leading to a tetrapodal array (Fig. 3E). N+Cα-H⋯O interactions in asymmetric catalysis involving ammonium salts has been extensively discussed,23 and the interaction we observe between these N+Cα-H donors and the pyridone carbonyl is reminiscent of those with DMF recently noted by Vetticatt, Waser and Adamo.19 To our knowledge Cβ–H interactions have not previously been proposed or observed for cinchona ammoniums, though Yamanaka and Shirakawa proposed a similar interaction in the optimized transition state for a tetraalkylammonium-catalysed aza-Diels–Alder reaction.24 Knowledge of these myriad interactions may inform efforts to understand and optimize cinchona alkaloid-catalysed asymmetric PTC through theory25 and experiment.26


image file: d2ob00177b-f3.tif
Fig. 3 (A) Synthesis of co-crystal 6. 3c-derived phenolate (in green), C4 catalyst quaternary cation (in purple) and neutral phenol 3c spectator (in grey). (B) Single crystal X-ray structure of ternary complex 6 (CCDC 2124143).20 The phenolate (in green) displays some disorder in the para-phenyl substituent. (C)–(E) The ensemble of intermolecular non-covalent interactions (dashed lines) displayed between the quinidinium cation and the neutral and anionic substrates. All contacts calculated to be shorter than the sum of VDW radii minus 0.2 Å are shown, except those directly between the neutral and anionic substrates. Bond lengths relevant to the non-covalent interactions are given (Å, in maroon). Species not involved in each interaction are omitted for clarity. In (E) the interaction occurs between a pyridone phenolate and quinolinium cation in adjacent asymmetric units, so this interaction is not visible in (B). Ar1 = 4-fluorophenyl; Ar2 = 9-anthracenyl.

Our initial interest in asymmetric pyridone synthesis stemmed from work generating axially chiral N-aryl quinolinium salts. We sought to determine if an N-aryl pyridinium species could be formed from these 2-pyridones (4). Treatment of 4i with Et3O+BF4 gave pyridinium tetrafluoroborate salt 7 in 91% yield, with a small reduction from 51% ee to 49% ee (Scheme 2). Since several enantioselective methods exist to generate 2-pyridones and related structures,1a–c this constitutes a general method to generate axially chiral pyridinium cations and their congeners.


image file: d2ob00177b-s2.tif
Scheme 2 Stereo-retentive synthesis of axially chiral pyridinium tetrafluoroborate salts.

In summary, chiral PTC enabled the DKR of N-aryl pyridones generating C–N axially chiral products in good to poor ee, with a strong substrate dependence. The difference in rotational barriers between the starting material and product were probed by a combination of experiment and quantum chemical calculation, revealing crucial non-covalent O–H⋯O and C–H⋯π interactions lying at the heart of this reaction manifold. Important non-covalent interactions were also revealed in the substrate–catalyst complex through X-ray diffraction that may aid in understanding the behaviour of cinchona-derived ammonium catalysts in this and other reactions.

Conflicts of interest

There are no conflicts to declare.

Notes and references

  1. (a) J. K. Cheng, S. H. Xiang, S. Li, L. Ye and B. Tan, Chem. Rev., 2021, 121, 4805–4902 CrossRef CAS PubMed; (b) E. Kumarasamy, R. Raghunathan, M. P. Sibi and J. Sivaguru, Chem. Rev., 2015, 115, 11239–11300 CrossRef CAS PubMed; (c) I. Takahashi, Y. Suzuki and O. Kitagawa, Org. Prep. Proced. Int., 2014, 46, 1–23 CrossRef CAS; (d) O. Kitagawa, Acc. Chem. Res., 2021, 54, 719–730 CrossRef CAS PubMed; (e) J. S. Sweet and P. C. Knipe, Synthesis, 2022 DOI:10.1055/s-0040-1719896.
  2. (a) X. Z. Fan, X. Zhang, C. Y. Li and Z. H. Gu, ACS Catal., 2019, 9, 2286–2291 CrossRef CAS; (b) T. Hirata, I. Takahashi, Y. Suzuki, H. Yoshida, H. Hasegawa and O. Kitagawa, J. Org. Chem., 2016, 81, 318–323 CrossRef CAS PubMed; (c) S. L. Li, C. Yang, Q. Wu, H. L. Zheng, X. Li and J. P. Cheng, J. Am. Chem. Soc., 2018, 140, 12836–12843 CrossRef CAS PubMed; (d) Z.-S. Liu, P.-P. Xie, Y. Hua, C. Wu, Y. Ma, J. Chen, H.-G. Cheng, X. Hong and Q. Zhou, Chem, 2021, 7, 1917–1932 CrossRef CAS; (e) N. Man, Z. Lou, Y. Li, H. Yang, Y. Zhao and H. Fu, Org. Lett., 2020, 22, 6382–6387 CrossRef CAS PubMed; (f) J. Y. Ong, X. Q. Ng, S. C. Lu and Y. Zhao, Org. Lett., 2020, 22, 6447–6451 CrossRef CAS PubMed; (g) Y.-B. Wang, S.-C. Zheng, Y.-M. Hu and B. Tan, Nat. Commun., 2017, 8, 15489 CrossRef PubMed; (h) G.-H. Yang, H. Zheng, X. Li and J.-P. Cheng, ACS Catal., 2020, 10, 2324–2333 CrossRef CAS; (i) D. Li, S. Wang, S. Ge, S. Dong and X. Feng, Org. Lett., 2020, 22, 5331–5336 CrossRef CAS PubMed; (j) G. Zheng, X. Li and J.-P. Cheng, Org. Lett., 2021, 23, 3997–4001 CrossRef CAS PubMed.
  3. (a) K. T. Barrett, A. J. Metrano, P. R. Rablen and S. J. Miller, Nature, 2014, 509, 71–75 CrossRef CAS PubMed; (b) K. T. Barrett and S. J. Miller, J. Am. Chem. Soc., 2013, 135, 2963–2966 CrossRef CAS PubMed; (c) M. E. Diener, A. J. Metrano, S. Kusano and S. J. Miller, J. Am. Chem. Soc., 2015, 137, 12369–12377 CrossRef CAS PubMed; (d) S. D. Vaidya, S. T. Toenjes, N. Yamamoto, S. M. Maddox and J. L. Gustafson, J. Am. Chem. Soc., 2020, 142, 2198–2203 CrossRef CAS PubMed; (e) Q.-J. Yao, P.-P. Xie, Y.-J. Wu, Y.-L. Feng, M.-Y. Teng, X. Hong and B.-F. Shi, J. Am. Chem. Soc., 2020, 142, 18266–18276 CrossRef CAS PubMed; (f) J. Zhang, Q. Xu, J. Wu, J. Fan and M. Xie, Org. Lett., 2019, 21, 6361–6365 CrossRef CAS PubMed; (g) S. Zhang, Q.-J. Yao, G. Liao, X. Li, H. Li, H.-M. Chen, X. Hong and B.-F. Shi, ACS Catal., 2019, 9, 1956–1961 CrossRef CAS.
  4. (a) N. Di Iorio, F. Champavert, A. Erice, P. Righi, A. Mazzanti and G. Bencivenni, Tetrahedron, 2016, 72, 5191–5201 CrossRef CAS; (b) N. Di Iorio, P. Righi, A. Mazzanti, M. Mancinelli, A. Ciogli and G. Bencivenni, J. Am. Chem. Soc., 2014, 136, 10250–10253 CrossRef CAS PubMed; (c) N. Di Iorio, L. Soprani, S. Crotti, E. Marotta, A. Mazzanti, P. Righi and G. Bencivenni, Synthesis, 2017, 49, 1519–1530 CrossRef CAS; (d) H. C. Liu, H. Y. Tao, H. J. Cong and C. J. Wang, J. Org. Chem., 2016, 81, 3752–3760 CrossRef CAS PubMed; (e) J. L. Zhang, Y. L. Zhang, L. L. Lin, Q. Yao, X. H. Liu and X. M. Feng, Chem. Commun., 2015, 51, 10554–10557 RSC; (f) J. W. Zhang, J. H. Xu, D. J. Cheng, C. Shi, X. Y. Liu and B. Tan, Nat. Commun., 2016, 7, 10677 CrossRef PubMed; (g) L. L. Zhang, J. W. Zhang, S. H. Xiang, Z. Guo and B. Tan, Org. Lett., 2018, 20, 6022–6026 CrossRef CAS PubMed.
  5. (a) M. Auge, A. Feraldi-Xypolia, M. Barbazanges, C. Aubert, L. Fensterbank, V. Gandon, E. Kolodziej and C. Ollivier, Org. Lett., 2015, 17, 3754–3757 CrossRef CAS PubMed; (b) K. Tanaka, Y. Takahashi, T. Suda and M. Hirano, Synlett, 2008, 1724–1728,  DOI:10.1055/s-2008-1078488.
  6. (a) H.-Y. Bai, F.-X. Tan, T.-Q. Liu, G.-D. Zhu, J.-M. Tian, T.-M. Ding, Z.-M. Chen and S.-Y. Zhang, Nat. Commun., 2019, 10, 3063 CrossRef PubMed; (b) J. Frey, S. Choppin, F. Colobert and J. Wencel-Delord, Chimia, 2020, 74, 883–889 CrossRef CAS PubMed; (c) J. Frey, A. Malekafzali, I. Delso, S. Choppin, F. Colobert and J. Wencel-Delord, Angew. Chem., Int. Ed., 2020, 59, 8844–8848 CrossRef CAS PubMed; (d) Q. Ren, T. Cao, C. He, M. Yang, H. Liu and L. Wang, ACS Catal., 2021, 11, 6135–6140 CrossRef CAS; (e) V. Thonnissen and F. W. Patureau, Chem. – Eur. J., 2021, 27, 7189–7192 CrossRef PubMed; (f) S. Brandes, M. Bella, A. Kjærsgaard and K. A. Jørgensen, Angew. Chem., Int. Ed., 2006, 45, 1147–1151 CrossRef CAS PubMed.
  7. J. S. Sweet, S. Rajkumar, P. Dingwall and P. C. Knipe, Eur. J. Org. Chem., 2021, 3980–3985 CrossRef CAS.
  8. A. J. Fugard, A. S. K. Lahdenpera, J. S. J. Tan, A. Mekareeya, R. S. Paton and M. D. Smith, Angew. Chem., Int. Ed., 2019, 58, 2795–2798 CrossRef CAS PubMed.
  9. B. E. Dial, P. J. Pellechia, M. D. Smith and K. D. Shimizu, J. Am. Chem. Soc., 2012, 134, 3675–3678 CrossRef CAS PubMed.
  10. J. A. Carmona, C. Rodríguez-Franco, R. Fernández, V. Hornillos and J. M. Lassaletta, Chem. Soc. Rev., 2021, 50, 2968–2983 RSC.
  11. Q.-H. Teng, X.-J. Peng, Z.-Y. Mo, Y.-L. Xu, H.-T. Tang, H.-S. Wang, H.-B. Sun and Y.-M. Pan, Green Chem., 2018, 20, 2007–2012 RSC.
  12. C. Wolf, D. H. Hochmuth, W. A. König and C. Roussel, Liebigs Ann., 1996, 1996, 357–363 CrossRef.
  13. M. Nishio and M. Hirota, Tetrahedron, 1989, 45, 7201–7245 CrossRef CAS.
  14. C. F. Macrae, I. Sovago, S. J. Cottrell, P. T. A. Galek, P. McCabe, E. Pidcock, M. Platings, G. P. Shields, J. S. Stevens, M. Towler and P. A. Wood, J. Appl. Crystallogr., 2020, 53, 226–235 CrossRef CAS PubMed.
  15. G. A. Molander and B. Canturk, Org. Lett., 2008, 10, 2135–2138 CrossRef CAS PubMed.
  16. W. B. Jennings, B. M. Farrell and J. F. Malone, Acc. Chem. Res., 2001, 34, 885–894 CrossRef CAS PubMed.
  17. S. E. Denmark, R. C. Weintraub and N. D. Gould, J. Am. Chem. Soc., 2012, 134, 13415–13429 CrossRef CAS PubMed.
  18. I. C. Nogueira and J. R. Pliego, Mol. Catal., 2021, 506, 111566 CrossRef CAS.
  19. G. Bencivenni, D. Salazar Illera, M. Moccia, K. N. Houk, J. A. Izzo, J. Novacek, P. Grieco, M. J. Vetticatt, M. Waser and M. F. A. Adamo, Chem. – Eur. J., 2021, 27, 11352–11366 CrossRef CAS PubMed.
  20. We thank the EPSRC UK National Crystallography Service at the University of Southampton for the collection of the crystallographic data. S. J. Coles and P. A. Gale, Chem. Sci., 2012, 3, 683–689 RSC.
  21. U. H. Dolling, P. Davis and E. J. J. Grabowski, J. Am. Chem. Soc., 1984, 106, 446–447 CrossRef CAS.
  22. H. Yang and M. W. Wong, J. Am. Chem. Soc., 2013, 135, 5808–5818 CrossRef CAS PubMed.
  23. (a) C. E. Cannizzaro and K. N. Houk, J. Am. Chem. Soc., 2002, 124, 7163–7169 CrossRef CAS PubMed; (b) T. Nakamura, K. Okuno, R. Nishiyori and S. Shirakawa, Chem. – Asian J., 2020, 15, 463–472 CrossRef CAS PubMed; (c) M. Yasui, A. Yamada, C. Tsukano, A. Hamza, I. Pápai and Y. Takemoto, Angew. Chem., Int. Ed., 2020, 59, 13479–13483 CrossRef CAS PubMed.
  24. M. Yamanaka, A. Mochizuki, T. Nakamura, K. Maruoka and S. Shirakawa, Heterocycles, 2020, 101, 580–592 CrossRef CAS.
  25. (a) C. Q. He, A. Simon, Y.-H. Lam, A. P. J. Brunskill, N. Yasuda, J. Tan, A. M. Hyde, E. C. Sherer and K. N. Houk, J. Org. Chem., 2017, 82, 8645–8650 CrossRef CAS PubMed; (b) J. R. Pliego, Org. Biomol. Chem., 2021, 19, 1900–1914 RSC; (c) E. De Freitas Martins and J. R. Pliego, ACS Catal., 2013, 3, 613–616 CrossRef CAS; (d) E. F. Martins and J. R. Pliego, J. Mol. Catal. A: Chem., 2016, 417, 192–199 CrossRef CAS.
  26. (a) S. E. Denmark and R. C. Weintraub, Heterocycles, 2010, 82, 1527–1540 CrossRef; (b) K. W. Lexa, K. M. Belyk, J. Henle, B. Xiang, R. P. Sheridan, S. E. Denmark, R. T. Ruck and E. C. Sherer, Org. Process Res. Dev., 2021 DOI:10.1021/acs.oprd.1c00155.

Footnote

Electronic supplementary information (ESI) available. DFT data relating to this study can be found at https://pure.qub.ac.uk with DOI: 10.17034/57c858bd-52ab-46c7-ac95-594e1fb66542. CCDC 2124143 and 2124208–2124211. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/d2ob00177b

This journal is © The Royal Society of Chemistry 2022
Click here to see how this site uses Cookies. View our privacy policy here.